Our Technology

Pioneering macromolecular design and peptidomimetic compound development through innovative platforms and cutting-edge computational tools.

Core Technologies

Our integrated technology stack incorporates artificial intelligence and computational biology for rapid molecular design. Our design process further implements in-vitro experimental analysis for orthogonal validation and iterative refinement.

AI-Driven Discovery

Emerging Technology

Machine learning algorithms and artificial intelligence platforms that accelerate the identification and optimization of novel peptidomimetic compounds.

Predictive modeling
Virtual screening
Property optimization
Lead compound identification

Macromolecular Engineering

Core Platform

Precision engineering of large molecular structures to create targeted therapeutic compounds with specific biological activities and improved drug-like properties.

Structure-based design
Molecular dynamics simulation
Binding affinity optimization
Selectivity enhancement

Peptidomimetic Design

Core Platform

Advanced computational modeling and synthesis of peptide-like molecules that mimic natural biological processes while offering enhanced stability and bioavailability. Applications also include peptidomimetic-drug conjugation systems (PDC's), which have use in drug distribution and payload delivery

Improved metabolic stability
Enhanced cell permeability
Reduced immunogenicity
Optimized pharmacokinetics

In-Vitro Testing

Core Platform

Characterization and orthogonal validation of lead candidates in cellular based systems ensures activity, highly sensitive and specificity with biological markers and disease states.

In-vitro assays
State-of-the-art analytical techniques
Cellular validation systems

Proprietary Platforms

Our integrated platforms accelerate discovery and development of next-generation therapeutics and diagnostics.

MacroDesign Suite

Comprehensive computational tools for macromolecular design and optimization using cutting-edge modeling techniques.

Key Capabilities

Macromolecular structure prediction
Molecular dynamics simulation
Free energy calculations
Protein-ligand docking

PeptiMimic Platform

Our proprietary platform for designing and screening peptidomimetic compounds with enhanced therapeutic properties.

Key Capabilities

Automated molecular design
Structure-activity relationship analysis
Pharmacokinetic optimization

Technology Applications

Our technologies address critical needs across multiple therapeutic areas and diagnostic applications.

Infectious Diseases

Developing peptidomimetic therapeutics targeting viral and bacterial pathogens with novel mechanisms of action.

Examples:

Anti-viral compoundsAntibiotic alternativesImmune modulators

Metabolic Disorders

Creating biosensors and therapeutics for diabetes, obesity, and other metabolic conditions.

Examples:

Insulin monitoringMetabolic pathway modulators

Immune Deficiency

Designing compounds that modulate immune system function for treating immunodeficiency disorders.

Examples:

Immune enhancersPathway inhibitorsCellular modulators

Innovation Process

Our systematic approach to technology development combines computational design, experimental validation, and iterative optimization to create breakthrough solutions.

1
Computational design and modeling
2
Synthesis and characterization
3
Biological evaluation and testing
4
Optimization and scale-up